Trials focused in treating OCD are however lacking
What matters most for results isn't the ingredient itself, which is well understood it's absorption format and patience
They are easy to handle and protect the skin, providing a film barrier when adhering and adhesive accessory
These findings align with previous research demonstrating the therapeutic potential of natural products like Cinnamaldehyde, Sarsasapogenin-AA13, Ginkgo biloba extracts, and active components of Andrographis paniculata in targeting these pathways for AD treatment [49, 89,90,91,92]
ClinicalTrials.gov identifier: NCT02166242
Also the percentages of ring stages (362% in the patient and 373% in the controls) and trophozoite/schizont stages (641% in the patient, 623% in the controls) did not differ significantly